Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$9,661,437 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
6 quarters on record
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Jun 30, 2026CallValue
$3,698,592
CallShares
23,600
PutValue
$4,059,048
PutShares
25,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TUDOR INVESTMENT CORP ET AL holds $79,702,583 across 6 Drug Manufacturers - General names.
All Filings in NVS
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,698,592 | 23,600 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $4,059,048 | 25,900 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $12,831,000 | 84,000 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $5,667,025 | 37,100 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $9,661,437 | 63,250 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,833,671 | 13,300 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $1,271,712 | 9,224 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $1,006,451 | 7,300 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $4,488,400 | 35,000 | Shares | Defined | 2025-12-09 | |
| 2025-09-30 | $2,782,808 | 21,700 | Call | Defined | 2025-12-09 | |
| 2025-06-30 | $1,984,564 | 16,400 | Call | Defined | 2025-08-14 | |
| 2024-03-31 | $374,828 | 3,875 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||